Option chain shows key data for Aptevo Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Aptevo Therapeutics.

Aptevo Therapeutics (NASDAQ:APVO) Stock, Option Chain

Aptevo Therapeutics

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Netflix

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AIEV

APVO

AREB

DRCT

GURE

HGTY

INFY

LITM

LXEH

MLGO

NFLX

SHF Holdings, Inc. - Class A Common Stock

SHFS

SXTC

Telecom Argentina Stet - France Telecom S.A.

VIAV

Why Netflix Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Gamestop, Lululemon, Uber, Ulta Beauty And Tesla: Why These 5 Stocks Are On Investors' Radars Today

ASIX

BIAF

GITS

GNPX

ICCT

KGEI

Penguin Solutions, Inc. - Ordinary Shares

PENG

PMAX

PTIX

RXST

TIVC

TOPW

TYRA

Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Biotech

Health Care

General

Aptevo Therapeutics reports strong remission rates in AML patients using mipletamig plus ven/aza, with Cohort 2 enrollment nearing completion.

Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment

Aptevo Therapeutics Inc

Press Releases

Aptevo Therapeutics Reports 2024 Financial Results And Provides A Business Update

Aptevo Therapeutics Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Aptevo to Participate in March Conferences

Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy

RAINIER Trial Data Update: Two Additional AML Patients Achieve Remission Within 30 Days of Treatment

Offerings

Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

$2 Stocks to Watch: PNPN.V, TIVC, APVO, OSRH, PRSO Biotech Breakthroughs, MedTech Momentum Metallic Metals Power Play & Signal Innovation

Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Aptevo Therapeutics Announces the Closing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

OSRH

PNPNF

PRSO

Aditxt

Apollomics

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

Bone Biologics

Entero Therapeutics

Genprex

GRI Bio

Mustang Bio

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Onconetix

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Qualigen Therapeutics, Inc. - Common Stock

Qualigen Therapeutics

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics

Shuttle Pharmaceuticals Holdings, Inc. - common stock

Shuttle Pharmaceuticals

SILO Pharma

Salarius Pharmaceuticals, Inc. - Common Stock

Salarius Pharmaceuticals

Synaptogenix

Tharimmune

ZyVersa Therapeutics, Inc. - Common Stock

ZyVersa Therapeutics

Roth MKM

Piper Sandler

Comments

Aptevo Therapeutics

Aptevo Therapeutics (APVO) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell